Minutes and jobs
EDITOR: This is a request to shoppers who choose to use the self-service check-out option at stores. Please don’t. It doesn’t save you any money, and you are contributing to the loss of jobs of local workers. Using a human checker probably takes a little more time, but how many of us are really on such a tight schedule that a few minutes are really that important?
The consequences of people using the self-serve feature is you save only a little time, more workers find themselves unemployed, you pay the same amount of money, and big corporations reap the benefits.
In my opinion, in the best of all worlds, everyone would be able to afford as many local products as are available, from a local source. Since that isn’t always the case, at least we can support our local workers. They are us; we are them.
EDITOR: As grandparents of a 4-year-old with the cystic fibrosis mutation G551D, we were extremely interested to read Joe Nocera’s June 21 column (“A costly miracle drug”). Nocera is correct, the cost for the Vertex drug Kalydeco is approximately $300,000 a year.
Mutation G551D is the particular mutation that is helped by Kalydeco, which is approved for people 6 years old and up. Our grandson, Waylon, is taking the “miracle” Kalydeco in a trial study in Seattle to try to obtain Food and Drug Administration approval to lower the age limit. Waylon has experienced incredible reductions in his symptoms since starting the drug.
As stated, cystic fibrosis is an orphaned disease. It is also a terminal disease, whose research funding comes primarily from the private sector, particularly the Cystic Fibrosis Foundation.